{"transactions":[{"id":4183,"issuer":{"id":2740,"kind":"organization","name":"Profusa, Inc.","symbol":"PFSA"},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-04T14:47:36.000Z","date":"2026-08-21","kind":"other","planned":false,"acquired":false,"shares":301991,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By NorthView Sponsor I LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On August 21, 2026, NorthView Sponsor I LLC distributed all its shares of Issuer's common stock to its members, including 32,018 shares to the reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Jack Stover is a manager of NorthView Sponsor I LLC and may be deemed to share beneficial ownership of the securities held by NorthView Sponsor I LLC. Mr. Stover disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-26-097490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026097490/ownership.xml","form_type":"4"}},{"id":4182,"issuer":{"id":2740,"kind":"organization","name":"Profusa, Inc.","symbol":"PFSA"},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-04T14:47:36.000Z","date":"2026-08-21","kind":"other","planned":false,"acquired":true,"shares":32018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pro rata distribution from NorthView Sponsor I LLC, of which the reporting person is a manager."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73 shares held directly by the reporting person."}],"balance_after":32091,"source":{"system":"sec-edgar","filing":"0001213900-26-097490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026097490/ownership.xml","form_type":"4"}},{"id":681147,"issuer":{"id":2740,"kind":"organization","name":"Profusa, Inc.","symbol":"PFSA"},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Promissory Note","published_at":"2026-08-20T00:13:53.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"price":0,"reported_value":1292521,"ownership":{"direct":false,"nature":"By NorthView Sponsor I LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The conversion price is equal to the higher of (i) $1.07 and (ii) the closing price of the Common Stock on the trading day immediately preceding the delivery of the Conversion Notice, as reported on The Nasdaq Stock Market, pursuant to Amendment No. 3 to the Note Modification and Conversion Agreement dated August 12, 2026. The pre-split conversion price of $1.07 per share is equivalent to $4.28 per share on a post-split basis following the 1-for-4 reverse stock split."},{"field":"reported_value","element":"transactionTotalValue","label":"F4","text":"Represents the conversion of $1,292,521 principal amount of the Convertible Promissory Note into 1,207,964 shares of Common Stock (301,991 shares on a post-split basis), reflecting conversion at the $1.07 per share ($4.28 per share on a post-split basis) price pursuant to the Conversion Notice dated August 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Note became convertible on May 4, 2026 (the Registration Effective Date), pursuant to Section 2.1 of the Note Modification and Conversion Agreement dated April 24, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On August 12, 2026, 1,207,964 shares of Common Stock were issued upon conversion of a portion of the Convertible Promissory Note. Following a 1-for-4 reverse stock split effected after the conversion, the number of shares held became 301,991."},{"field":"valueOwnedAfter","element":"valueOwnedFollowingTransaction","label":"F6","text":"Represents the remaining principal balance of the Note following conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Jack Stover is a manager of NorthView Sponsor I LLC and may be deemed to share beneficial ownership of the securities held by NorthView Sponsor I LLC. Mr. Stover disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"derivative":{"exercise_price":4.28,"exercise_date":"2026-05-04","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":301991},"source":{"system":"sec-edgar","filing":"0001213900-26-091839","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1203603/000121390026091839/ownership.xml","form_type":"4"}},{"id":681146,"issuer":{"id":2740,"kind":"organization","name":"Profusa, Inc.","symbol":"PFSA"},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-20T00:13:53.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":301991,"price":4.28,"value":1292521.48,"ownership":{"direct":false,"nature":"By NorthView Sponsor I LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 12, 2026, 1,207,964 shares of Common Stock were issued upon conversion of a portion of the Convertible Promissory Note. Following a 1-for-4 reverse stock split effected after the conversion, the number of shares held became 301,991."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The conversion price is equal to the higher of (i) $1.07 and (ii) the closing price of the Common Stock on the trading day immediately preceding the delivery of the Conversion Notice, as reported on The Nasdaq Stock Market, pursuant to Amendment No. 3 to the Note Modification and Conversion Agreement dated August 12, 2026. The pre-split conversion price of $1.07 per share is equivalent to $4.28 per share on a post-split basis following the 1-for-4 reverse stock split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On August 12, 2026, 1,207,964 shares of Common Stock were issued upon conversion of a portion of the Convertible Promissory Note. Following a 1-for-4 reverse stock split effected after the conversion, the number of shares held became 301,991."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Jack Stover is a manager of NorthView Sponsor I LLC and may be deemed to share beneficial ownership of the securities held by NorthView Sponsor I LLC. Mr. Stover disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":301991,"source":{"system":"sec-edgar","filing":"0001213900-26-091839","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203603/000121390026091839/ownership.xml","form_type":"4"}},{"id":709983,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-15T01:57:35.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date."}],"balance_after":14150,"derivative":{"exercise_price":0.68,"exercise_date":"2027-07-09","expiration_date":"2036-07-09","underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0001203603-26-000003","document":"form4-07152026_010731.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000120360326000003/form4-07152026_010731.xml","form_type":"4"}},{"id":789636,"issuer":{"id":2740,"kind":"organization","name":"Profusa, Inc.","symbol":"PFSA"},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2026-05-06T14:42:51.000Z","date":"2026-05-04","kind":"purchase","planned":false,"acquired":false,"price":1869796,"reported_value":1869796,"ownership":{"direct":false,"nature":"By NorthView Sponsor I LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The conversion price is equal to the greater of (i) 95% of the closing price of the Common Stock on the Conversion Date and (ii) $0.35 per share, pursuant to the Note Modification and Conversion Agreement dated April 24, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Note became exercisable (convertible) on the Registration Effective Date, pursuant to Section 2.1 of the Note Modification and Conversion Agreement dated April 24, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Represents the conversion of the entire outstanding principal balance of the Second Amended and Restated Promissory Note, dated April 6, 2026, in the amount of $1,869,796 into 5,342,274 shares of Common Stock, reflecting conversion at the $0.35 per share floor price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Knechtel is the managing member of NorthView Sponsor I LLC and may be deemed to share beneficial ownership of the securities held by NorthView Sponsor I LLC. Mr. Knechtel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"derivative":{"exercise_price":0.35,"exercise_date":"2026-05-04","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":5342274},"source":{"system":"sec-edgar","filing":"0001213900-26-052627","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203603/000121390026052627/ownership.xml","form_type":"4"}},{"id":851703,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-10T23:16:20.000Z","date":"2026-03-08","kind":"grant","planned":false,"acquired":true,"shares":33435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof.  The stock options under this award will vest 100% on the first anniversary of the grant date."}],"balance_after":33435,"derivative":{"exercise_price":1.6,"exercise_date":"2027-03-08","expiration_date":"2036-03-08","underlying":"Common Stock","underlying_shares":33435},"source":{"system":"sec-edgar","filing":"0001203603-26-000001","document":"form4-03102026_110316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000120360326000001/form4-03102026_110316.xml","form_type":"4"}},{"id":926857,"issuer":{"id":2740,"kind":"organization","name":"Profusa, Inc.","symbol":"PFSA"},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-01-30T21:27:03.000Z","date":"2026-01-26","kind":"other","planned":false,"acquired":true,"shares":380280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the distribution for no consideration by NorthView Sponsor I LLC (the \"Sponsor\") to the Reporting Person of (i) 553,665 shares of Common Stock, and (ii) 380,280 warrants to purchase shares of Common Stock, in connection with a pro rata distribution of Issuer securities held by the Sponsor to its members."}],"balance_after":380280,"derivative":{"exercise_price":11.5,"exercise_date":"2026-01-26","expiration_date":"2030-07-11","underlying":"Common Stock","underlying_shares":380280},"source":{"system":"sec-edgar","filing":"0001213900-26-010228","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1203603/000121390026010228/ownership.xml","form_type":"4"}},{"id":926856,"issuer":{"id":2740,"kind":"organization","name":"Profusa, Inc.","symbol":"PFSA"},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T21:27:03.000Z","date":"2026-01-26","kind":"other","planned":false,"acquired":true,"shares":553665,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the distribution for no consideration by NorthView Sponsor I LLC (the \"Sponsor\") to the Reporting Person of (i) 553,665 shares of Common Stock, and (ii) 380,280 warrants to purchase shares of Common Stock, in connection with a pro rata distribution of Issuer securities held by the Sponsor to its members."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the distribution for no consideration by NorthView Sponsor I LLC (the \"Sponsor\") to the Reporting Person of (i) 553,665 shares of Common Stock, and (ii) 380,280 warrants to purchase shares of Common Stock, in connection with a pro rata distribution of Issuer securities held by the Sponsor to its members."}],"balance_after":553665,"source":{"system":"sec-edgar","filing":"0001213900-26-010228","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203603/000121390026010228/ownership.xml","form_type":"4"}},{"id":927778,"issuer":{"id":2740,"kind":"organization","name":"Profusa, Inc.","symbol":"PFSA"},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-01-29T18:55:20.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":52866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an annual director award of options to purchase common stock. The options vest on the first anniversary of the Closing."}],"balance_after":52866,"derivative":{"exercise_price":0.35,"exercise_date":"2026-01-26","expiration_date":"2036-01-26","underlying":"Common Stock","underlying_shares":52866},"source":{"system":"sec-edgar","filing":"0001213900-26-009374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1203603/000121390026009374/ownership.xml","form_type":"4"}},{"id":927777,"issuer":{"id":2740,"kind":"organization","name":"Profusa, Inc.","symbol":"PFSA"},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-01-29T18:55:20.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":221794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an inaugural director award of options to purchase common stock. The options vest in three equal annual increments over a period of three years from the closing of the business combination between the Issuer (formerly known as NorthView Acquisition Corp.) and Profusa, Inc. (the \"Closing\")."}],"balance_after":221794,"derivative":{"exercise_price":0.35,"exercise_date":"2026-01-26","expiration_date":"2036-01-26","underlying":"Common Stock","underlying_shares":221794},"source":{"system":"sec-edgar","filing":"0001213900-26-009374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203603/000121390026009374/ownership.xml","form_type":"4"}},{"id":968026,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-12-16T23:20:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":24629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on the first anniversary of the grant date."}],"balance_after":24629,"derivative":{"exercise_price":2.33,"exercise_date":"2026-12-12","expiration_date":"2035-12-12","underlying":"Common Stock","underlying_shares":24629},"source":{"system":"sec-edgar","filing":"0001203603-25-000006","document":"form4-12162025_111205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000120360325000006/form4-12162025_111205.xml","form_type":"4"}},{"id":968025,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-16T23:20:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":6157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis."}],"balance_after":6165,"source":{"system":"sec-edgar","filing":"0001203603-25-000006","document":"form4-12162025_111205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000120360325000006/form4-12162025_111205.xml","form_type":"4"}},{"id":1018773,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-10-16T00:05:11.000Z","date":"2025-10-12","kind":"grant","planned":false,"acquired":true,"shares":11530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the first anniversary of the grant date."}],"balance_after":11530,"derivative":{"exercise_price":3.01,"exercise_date":"2026-10-12","expiration_date":"2035-10-12","underlying":"Common Stock","underlying_shares":11530},"source":{"system":"sec-edgar","filing":"0001203603-25-000005","document":"form4-10162025_121008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000120360325000005/form4-10162025_121008.xml","form_type":"4"}},{"id":1104178,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-06-23T21:54:01.000Z","date":"2025-06-19","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 100% on the first anniversary of the grant date."}],"balance_after":23000,"derivative":{"exercise_price":1.65,"exercise_date":"2026-06-19","expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001415889-25-017996","document":"form4-06232025_090657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588925017996/form4-06232025_090657.xml","form_type":"4"}},{"id":1808821,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2023-08-14T21:52:24.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":66468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 100% on the first anniversary of the grant date."}],"balance_after":66468,"derivative":{"exercise_price":1.02,"exercise_date":"2024-08-10","expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":66468},"source":{"system":"sec-edgar","filing":"0001415889-23-012232","document":"form4-08142023_090802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923012232/form4-08142023_090802.xml","form_type":"4"}},{"id":2178525,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2022-08-19T21:10:11.000Z","date":"2022-08-18","kind":"grant","acquired":true,"shares":66468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 100% on the first anniversary of the grant date."}],"balance_after":66468,"derivative":{"exercise_price":1.26,"exercise_date":"2023-08-18","expiration_date":"2032-08-18","underlying":"Common Stock","underlying_shares":66468},"source":{"system":"sec-edgar","filing":"0001415889-22-008914","document":"form4-08192022_050801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588922008914/form4-08192022_050801.xml","form_type":"4"}},{"id":2459814,"issuer":{"id":2740,"kind":"organization","name":"Profusa, Inc.","symbol":"PFSA"},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":68230,"kind":"organization","name":"NorthView Sponsor I, LLC","position":2,"cik":"0001890761","reported_name":"NorthView Sponsor I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Private Warrants to purchase common stock","published_at":"2021-12-23T22:27:48.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":5162500,"price":1,"value":5162500.0,"ownership":{"direct":false,"nature":"By NorthView Sponsor I, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"NorthView Sponsor I, LLC (\"Sponsor\") purchased 5,162,500 warrants on December 20, 2021, as described in the issuer's registration statement on Form S-1 (File No. 333-257156), in a private placement of warrants at a price of $1.00 per private placement warrant. Each whole private placement warrant is exercisable to purchase one share of common stock at a price of $11.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants become exercisable on the later of (i) 30 days after the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrants expire five years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the Form S-1 (File No. 333-257156)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The warrants are held by Sponsor. Jack Stover is the manager of the Sponsor. Mr. Stover disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein."}],"balance_after":5162500,"derivative":{"exercise_price":11.5,"underlying":"Common stock","underlying_shares":5162500},"source":{"system":"sec-edgar","filing":"0001213900-21-067370","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890761/000121390021067370/ownership.xml","form_type":"4"}},{"id":2621484,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2021-07-30T23:21:47.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 100% on the first anniversary of the grant date."}],"balance_after":13000,"derivative":{"exercise_price":4.97,"exercise_date":"2022-07-30","expiration_date":"2031-07-30","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001179110-21-007792","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021007792/edgar.xml","form_type":"4"}},{"id":2962249,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former officer and director"}}],"security":"Stock option (right to buy)","published_at":"2020-12-02T22:02:03.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest immediately."}],"balance_after":43750,"derivative":{"exercise_price":6,"expiration_date":"2030-11-30","underlying":"Common Stock","underlying_shares":43750},"source":{"system":"sec-edgar","filing":"0001493152-20-022840","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315220022840/ownership.xml","form_type":"4"}},{"id":3085071,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Appreciation Right","published_at":"2020-07-10T21:36:49.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock appreciation rights vest 100% on the first anniversary of the grant date."}],"balance_after":125000,"derivative":{"exercise_price":0.56,"exercise_date":"2021-07-09","expiration_date":"2030-07-09","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001179110-20-008207","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020008207/edgar.xml","form_type":"4"}},{"id":3182125,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-06T21:46:58.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":7188,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30271,"source":{"system":"sec-edgar","filing":"0001493152-20-005921","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315220005921/ownership.xml","form_type":"4"}},{"id":3303665,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-24T21:34:40.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is eligible to vest and become exercisable in equal installments on each of the first three anniversaries of the date of grant, subject to the reporting person's continued service with the Issuer through the applicable vesting dates."}],"balance_after":35000,"derivative":{"exercise_price":8.18,"expiration_date":"2030-01-22","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001192482-20-000059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000119248220000059/edgar.xml","form_type":"4"}},{"id":3454396,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2019-07-29T21:21:51.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":5833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 100% on the first anniversary of the grant date."}],"balance_after":5833,"derivative":{"exercise_price":3.39,"exercise_date":"2020-07-26","expiration_date":"2029-07-26","underlying":"Common Stock","underlying_shares":5833},"source":{"system":"sec-edgar","filing":"0001179110-19-008865","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911019008865/edgar.xml","form_type":"4"}},{"id":3594579,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-15T20:59:56.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":347688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest and become exercisable over a three-year period, in equal installments, commencing on March 13, 2020, subject to the reporting person's continued service with the Issuer."}],"balance_after":347688,"derivative":{"exercise_price":0.98,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":347688},"source":{"system":"sec-edgar","filing":"0001192482-19-000148","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000119248219000148/edgar.xml","form_type":"4"}},{"id":3594578,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-15T20:59:56.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":86922,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest annually, in equal installments, over  a three-year period, commencing on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer."}],"balance_after":427300,"source":{"system":"sec-edgar","filing":"0001192482-19-000148","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000119248219000148/edgar.xml","form_type":"4"}},{"id":3605485,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-08T21:18:35.000Z","date":"2018-12-05","kind":"grant","acquired":true,"shares":348000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On December 6, 2018, the award of stock options was inadvertently overstated on the reporting person's Form 4 filing as 375,000 stock options. 348,000 stock options were awarded."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options vest and become exercisable over a three-year period, in equal installments, commencing on December 5, 2019, subject to the reporting person's continued service with the Issuer."}],"balance_after":348000,"derivative":{"exercise_price":1.08,"expiration_date":"2028-12-05","underlying":"Common Stock","underlying_shares":348000},"source":{"system":"sec-edgar","filing":"0001192482-19-000124","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000119248219000124/edgar.xml","form_type":"4/A","original_submission_date":"2018-12-06"}},{"id":3605484,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-08T21:18:35.000Z","date":"2018-12-05","kind":"grant","acquired":true,"shares":87000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 6, 2018, the award of restricted stock units was inadvertently omitted from the reporting person's Form 4 filing.  The restricted stock units vest annually, in equal installments, over  a three-year period, commencing on December 5, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer."}],"balance_after":340378,"source":{"system":"sec-edgar","filing":"0001192482-19-000124","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000119248219000124/edgar.xml","form_type":"4/A","original_submission_date":"2018-12-06"}},{"id":3742958,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-06T22:06:58.000Z","date":"2018-12-05","kind":"grant","acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on December 5, 2019, subject to the reporting person's continued service with the Issuer."}],"balance_after":375000,"derivative":{"exercise_price":1.08,"expiration_date":"2028-12-05","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001192482-18-000490","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000119248218000490/edgar.xml","form_type":"4"}},{"id":3742957,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-06T22:06:58.000Z","date":"2018-12-05","kind":"grant","acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted units vest annually, in equal installments, over  a three-year period, commencing on December 6, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted unit represents the contingent right to receive one share of common stock of the Issuer."}],"balance_after":313378,"source":{"system":"sec-edgar","filing":"0001192482-18-000490","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000119248218000490/edgar.xml","form_type":"4"}},{"id":3859172,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2018-07-30T21:31:39.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 100% on the first anniversary of the grant date."}],"balance_after":87500,"derivative":{"exercise_price":0.46,"exercise_date":"2019-07-26","expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001179110-18-010014","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911018010014/edgar.xml","form_type":"4"}},{"id":3952247,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2018-05-01T22:30:25.000Z","date":"2018-04-27","kind":"purchase","acquired":true,"shares":47100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock and warrants reported on this Form 4 were acquired in a public offering, by Onconova Therapeutics, Inc. (the Company), of units which included one share of common stock and one warrant. The public offering price for each unit was $0.425. The public offering, during which the Company also sold other securities, was pursuant to the Company's effective registration statement on Form S-1 (File No. 333-224315)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrants are exercisable immediately at an exercise price of $0.425 per 0.025 share of Series B Convertible Preferred Stock and will expire on the 18-month anniversary of the date on which the Company publicly announces through the filing of a Current Report on Form 8-K that a Charter Amendment, increasing the number of available common shares, has been filed with the Secretary of State of the State of Delaware."}],"balance_after":47100,"derivative":{"exercise_price":0.425,"exercise_date":"2018-04-27","underlying":"Series B Convertible Preferred Stock","underlying_shares":1177.5},"source":{"system":"sec-edgar","filing":"0001179110-18-006015","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911018006015/edgar.xml","form_type":"4"}},{"id":3952246,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-01T22:30:25.000Z","date":"2018-04-27","kind":"purchase","acquired":true,"shares":47100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock and warrants reported on this Form 4 were acquired in a public offering, by Onconova Therapeutics, Inc. (the Company), of units which included one share of common stock and one warrant. The public offering price for each unit was $0.425. The public offering, during which the Company also sold other securities, was pursuant to the Company's effective registration statement on Form S-1 (File No. 333-224315)."}],"balance_after":47110,"source":{"system":"sec-edgar","filing":"0001179110-18-006015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911018006015/edgar.xml","form_type":"4"}},{"id":4004690,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-09T22:32:46.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":224000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on March 7, 2019, subject to the reporting person's continued service with the Issuer."}],"balance_after":224000,"derivative":{"exercise_price":1.01,"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":224000},"source":{"system":"sec-edgar","filing":"0001493152-18-003194","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315218003194/form4.xml","form_type":"4"}},{"id":4004689,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-09T22:32:46.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":56000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted units vest annually, in equal installments, over a three-year period, commencing on March 7, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted unit represents the contingent right to receive one share of common stock of Interpace Diagnostics Group, Inc. (the \"Issuer\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects 1-for-10 reverse stock split, effective as of December 28, 2016."}],"balance_after":75738,"source":{"system":"sec-edgar","filing":"0001493152-18-003194","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315218003194/form4.xml","form_type":"4"}},{"id":4201339,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-09-27T21:11:12.000Z","date":"2017-09-26","kind":"grant","acquired":true,"shares":345000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests and becomes exercisable over a period of one year in twelve equal installments, commencing on the 15th day of each calendar month, subject to the reporting person's continued service with the issuer."}],"balance_after":345000,"derivative":{"exercise_price":1.45,"expiration_date":"2018-09-26","underlying":"Common Stock","underlying_shares":345000},"source":{"system":"sec-edgar","filing":"0001493152-17-010979","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315217010979/form4.xml","form_type":"4"}},{"id":4283999,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2017-06-13T21:00:57.000Z","date":"2017-06-12","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over one year from the grant date in 12 equal monthly installments."}],"balance_after":1500,"derivative":{"exercise_price":1.94,"expiration_date":"2027-06-12","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001179110-17-008993","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911017008993/edgar.xml","form_type":"4"}},{"id":4378976,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-20T20:09:15.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":134602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award vests and becomes exercisable over a one-year period, commencing on March 16, 2017, in twelve equal installments, on the 15th day of each calendar month, subject to the reporting person's continued service with the issuer."}],"balance_after":134602,"derivative":{"exercise_price":2.12,"expiration_date":"2027-03-16","underlying":"Common Stock","underlying_shares":134602},"source":{"system":"sec-edgar","filing":"0001192482-17-000080","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000119248217000080/edgar.xml","form_type":"4"}},{"id":4578822,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":2741,"kind":"person","name":"STOVER JACK E","position":1,"cik":"0001203603","reported_name":"STOVER JACK E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2016-10-18T20:25:09.000Z","date":"2016-10-14","kind":"grant","acquired":true,"shares":326368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over a period of one year."}],"balance_after":326368,"derivative":{"exercise_price":0.16,"expiration_date":"2026-10-14","underlying":"Common Stock","underlying_shares":326368},"source":{"system":"sec-edgar","filing":"0001192482-16-000733","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000119248216000733/edgar.xml","form_type":"4"}}]}